BMC Medical Research Methodology

Papers
(The H4-Index of BMC Medical Research Methodology is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Mind the gap: covariate constrained randomisation can protect against substantial power loss in parallel cluster randomised trials421
Does imbalance in chest X-ray datasets produce biased deep learning approaches for COVID-19 screening?315
coreSCD: multi-stakeholder consensus on core outcomes for sickle cell disease clinical trials258
regCOVID: Tracking publications of registered COVID-19 studies193
A gated group sequential design for seamless Phase II/III trial with subpopulation selection188
Comparing statistical methods in assessing the prognostic effect of biomarker variability on time-to-event clinical outcomes123
Understanding facilitators of research participation among adults with self-reported chronic pain – a survey examining hypothetical research participation121
Correction: In health research publications, the number of authors is strongly associated with collective self-citations but less so with citations by others107
Pre-statistical harmonization of behavioral instruments across eight surveys and trials93
More than one third of clinical practice guidelines on low back pain overlap in AGREE II appraisals. Research wasted?89
Should RECOVERY have used response adaptive randomisation? Evidence from a simulation study83
Design and analysis of outcomes following SARS-CoV-2 infection in veterans73
Recruitment methods and yield rates in a clinical trial of physical exercise for older adults with hypertension—HAEL Study: a study within a trial72
How likely is unmeasured confounding to explain meta-analysis-derived associations between alcohol, other substances, and mood-related conditions with HIV risk behaviors?69
Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiased68
Statistical methods in the analysis of multicentre HIV randomized controlled trials in the African region: a scoping review61
External validation of existing dementia prediction models on observational health data61
Choices of measures of association affect the visualisation and composition of the multimorbidity networks60
Developing survey weights to ensure representativeness in a national, matched cohort study: results from the children and young people with Long Covid (CLoCk) study58
A Bayesian network perspective on neonatal pneumonia in pregnant women with diabetes mellitus58
MetaAnalyst: a user-friendly tool for metagenomic biomarker detection and phenotype classification56
A framework to model global, regional, and national estimates of intimate partner violence55
Methodological aspects for accelerometer-based assessment of physical activity in heart failure and health55
Technologies for frailty, comorbidity, and multimorbidity in older adults: a systematic review of research designs53
A data-driven pipeline to extract potential adverse drug reactions through prescription, procedures and medical diagnoses analysis: application to a cohort study of 2,010 patients taking hydroxychloro53
Causal effect of chemotherapy received dose intensity on survival outcome: a retrospective study in osteosarcoma51
Estimation of marginal structural models under irregular visits and unmeasured confounder: calibrated inverse probability weights50
The impact of iterative removal of low-information cluster-period cells from a stepped wedge design47
Contextual effects: how to, and how not to, quantify them47
Clinical systematic reviews – a brief overview46
CalScope: methodology and lessons learned for conducting a remote statewide SARS-CoV-2 seroprevalence study in California using an at-home dried blood spot collection kit and online survey45
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group44
Modelling of intensive care unit (ICU) length of stay as a quality measure: a problematic exercise44
Joint modelling of multivariate longitudinal clinical laboratory safety outcomes, concomitant medication and clinical adverse events: application to artemisinin-based treatment during pregnancy clinic43
Using group testing in a two-phase epidemiologic design to identify the effects of a large number of antibody reactions on disease risk43
The reliance on conceptual frameworks in qualitative research – a way forward42
An algorithm to assess importance of predictors in systematic reviews of prediction models: a case study with simulations42
Analytical challenges in estimating the effect of exposures that are bounded by follow-up time: experiences from the Blood Stream Infection—Focus on Outcomes study41
A study within a trial (SWAT) of clinical trial feasibility and barriers to recruitment in the United Kingdom – the CapaCiTY programme experience39
The effect of high prevalence of missing data on estimation of the coefficients of a logistic regression model when using multiple imputation39
0.036678075790405